Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute ("malignant") myelosclerosis.

R M Bearman, G A Pangalis, H Rappaport

    Cancer
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Acute myelosclerosis is a distinct entity characterized by pancytopenia and fibrotic bone marrow. Strict criteria help differentiate it from other myeloproliferative disorders.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Monoclonal and/or Oligoclonal Immunoglobulins in Sera of Patients with Non-Hodgkin's Lymphomas, Determined by Iso-Electric Focusing and Immunoblotting.

    Leukemia & lymphoma·2016
    Same author

    Prolonged Intermittent Chlorambucil Administration in B-Chronic Lymphocytic Leukemia: Experience from a Single Hematology Unit.

    Leukemia & lymphoma·2016
    Same author

    Chronic Lymphocytic Leukemia in Younger Adults: Preliminary Results of a Study Based on 454 Patients-IWCLL/Working Group.

    Leukemia & lymphoma·2016
    Same author

    Chronic Lymphocytic Leukemia in Young Adults: Report of Six Cases Under the Age of 30 Years.

    Leukemia & lymphoma·2016
    Same author

    A New Mononuclear Cell (MNC) RNase H Activity-Based Parameter (ψ) With Possible Prognostic Value in Assessing Progression in Acute Myeloid Leukaemia.

    Leukemia & lymphoma·2016
    Same author

    Expression of c-myc p62 Protein in Non-Hodgkin's Lymphomas.

    Leukemia & lymphoma·2016
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    Same journal

    Most older patients with advanced cancer prioritize QOL over extending survival: A secondary analysis of the GAP70+ trial found that among adults aged 70 and older with advanced, noncurable cancer, nearly three-quarters prioritized maintaining QOL.

    Cancer·2026
    Same journal

    Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

    Cancer·2026
    See all related articles

    Area of Science:

    • Hematology
    • Oncology
    • Pathology

    Background:

    • Acute myelosclerosis is a rare myeloproliferative neoplasm.
    • Accurate diagnosis is crucial for patient management and prognosis.

    Observation:

    • Analysis of 7 patients and 49 literature cases revealed characteristic pancytopenia.
    • Fibrotic bone marrow with hyperplasia and immature cell lines, especially megakaryocytes, were noted.
    • Absence of splenomegaly and a rapid fatal course are typical features.

    Findings:

    • Only 25% of reported cases met strict criteria for acute myelosclerosis.
    • Other cases represented diverse myeloproliferative disorders, including chronic myelosclerosis with accelerated phase and acute myeloblastic leukemia with fibrosis.
    • The study establishes distinct clinicopathologic criteria for acute myelosclerosis.

    Related Experiment Videos

    Implications:

    • Refined diagnostic criteria improve the accurate classification of myeloproliferative neoplasms.
    • Distinguishing acute myelosclerosis aids in understanding its unique biology and clinical behavior.
    • This differentiation is essential for targeted therapeutic strategies and prognostic assessments.